PriceTargets.com logo

Apria - APR Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$37.50 As of 03/29/2022 01:00 AM ET
+0 (0.00%)
Get New Apria Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for APR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for APR

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Apria in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $37.50.

This chart shows the closing price for APR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Apria. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/8/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/6/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/7/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/11/2022UBS GroupDowngradeBuy ➝ Neutral$37.50Low
1/10/2022Piper SandlerDowngradeOverweight ➝ NeutralLow
1/10/2022CitigroupInitiated CoverageBuy ➝ Buy$39.00High
11/19/2021CitigroupInitiated CoverageBuyLow
11/16/2021Piper SandlerBoost TargetOverweight$35.00 ➝ $40.00Low
11/8/2021CitigroupInitiated CoverageBuy$43.00Low
8/6/2021CitigroupBoost TargetBuy$33.00 ➝ $38.00High
8/6/2021Piper SandlerBoost TargetOverweight$33.00 ➝ $35.00High
7/19/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$32.00 ➝ $29.00High
6/30/2021CitigroupInitiated CoverageBuyMedium
5/17/2021CitigroupInitiated CoverageBuyMedium
4/15/2021Piper SandlerBoost TargetOverweight$29.00 ➝ $33.00Low
3/31/2021CitigroupBoost Target$26.00 ➝ $30.00High
3/31/2021Piper SandlerBoost TargetOverweight$27.00 ➝ $29.00High
3/8/2021UBS GroupInitiated CoverageBuy$26.00Medium
3/8/2021Bank of AmericaInitiated CoverageBuy$27.00High
3/8/2021CitigroupInitiated CoverageBuy$26.00High
3/8/2021Piper SandlerInitiated CoverageOverweightHigh
3/8/2021The Goldman Sachs GroupInitiated CoverageBuy$30.00High
(Data available from 5/1/2019 forward)

News Sentiment Rating

0.15 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/4/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/3/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/3/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/2/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/1/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/2/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/1/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/1/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
Apria logo
Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc.
Read More

Today's Range

Now: $37.50
Low: $37.50
High: $37.50

50 Day Range

MA: $37.45
Low: $37.26
High: $37.50

52 Week Range

Now: $37.50
Low: $22.36
High: $40.00

Volume

N/A

Average Volume

682,285 shs

Market Capitalization

$1.34 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Apria?

The following Wall Street analysts have issued research reports on Apria in the last year:
View the latest analyst ratings for APR.

What is the current price target for Apria?

0 Wall Street analysts have set twelve-month price targets for Apria in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Apria in the next year.
View the latest price targets for APR.

What is the current consensus analyst rating for Apria?

Apria currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for APR.

What other companies compete with Apria?

Other companies that are similar to Apria include AdaptHealth, Addus HomeCare, BrightSpring Health Services, Enhabit and Aveanna Healthcare. Learn More about companies similar to Apria.

How do I contact Apria's investor relations team?

Apria's physical mailing address is 7353 COMPANY DRIVE, INDIANAPOLIS IN, 46237. The company's listed phone number is 800-990-9799 and its investor relations email address is [email protected]. The official website for Apria is www.apria.com. Learn More about contacing Apria investor relations.